I was unable to find specific information on a Yervoy discount. However, I can provide some context regarding Yervoy's cost and potential ways to save on medication expenses.
Yervoy (ipilimumab) is a medication used to treat melanoma, a type of skin cancer, and is also used in some cases of colorectal cancer and lung cancer [1]. The cost of Yervoy can be high, as it is a specialty medication. According to GoodRx, the average retail price for a typical dose (3 mg per kilogram of body weight, intravenous) can range from $14,000 to $30,000 or more, depending on the patient's weight [2].
There are several ways to potentially reduce the cost of Yervoy:
1. Insurance coverage: If you have health insurance, check with your provider to determine your coverage and out-of-pocket costs for Yervoy.
2. Patient Assistance Programs (PAPs): Pharmaceutical companies often offer PAPs to help eligible patients afford their medications. Bristol Myers Squibb, the manufacturer of Yervoy, provides a patient assistance program called BMS Access Support [3]. You can visit their website or call 1-800-861-0048 for more information.
3. Financial assistance resources: Non-profit organizations like NeedyMeds [4] and RxAssist [5] provide information on patient assistance programs, discount cards, and other resources to help reduce the cost of prescription medications.
4. DrugPatentWatch.com: This website [6] can provide information on drug patents and potential generic alternatives, which may become available in the future and help lower costs.
Sources:
[1] Yervoy (ipilimumab) Injection, for intravenous use, prescribing information. Bristol-Myers Squibb Company. 2021. <https://packageinserts.bms.com/pi/pi_yervoy.pdf>
[2] GoodRx. Yervoy (ipilimumab) Prices. <https://www.goodrx.com/yervoy>
[3] BMS Access Support. Bristol-Myers Squibb Company. <https://www.bmsaccesssupport.com/>
[4] NeedyMeds. Patient Assistance Programs. <https://www.needymeds.org/patient-assistance-programs>
[5] RxAssist. Patient Assistance Programs. <https://www.rxassist.org/patients/programs>
[6] DrugPatentWatch.com. <https://www.DrugPatentWatch.com>